Filing Details

Accession Number:
0000914190-15-000342
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-19 16:39:52
Reporting Period:
2015-08-17
Filing Date:
2015-08-19
Accepted Time:
2015-08-19 16:39:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180145 Cardiovascular Systems Inc CSII Surgical & Medical Instruments & Apparatus (3841) 411698056
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1428216 J. Robert Thatcher 1225 Old Highway 8 Nw
St. Paul MN 55112
Chief Healthcare Policy Off'r No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-08-17 1,433 $24.02 139,770 No 4 S Direct
Common Stock Disposition 2015-08-18 1,527 $23.97 138,243 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $12.37 2015-10-16 64,700 64,700 Direct
Common Stock Stock Option (right to buy) $8.83 2017-04-17 265 265 Direct
Common Stock Stock Option (right to buy) $12.15 2017-12-11 32,350 32,350 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2015-10-16 64,700 64,700 Direct
2017-04-17 265 265 Direct
2017-12-11 32,350 32,350 Direct
Footnotes
  1. In connection with the vesting and delivery of restricted stock and pursuant to a Rule 10b5-1 trading plan, on the date the shares were sold the net proceeds were used to pay required withholding taxes.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.98 to $24.08 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.82 to $24.05 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. Fully exercisable.